Mice Transgenic for Baff Develop Lymphocytic Disorders along with Autoimmune Manifestations

Fabienne Mackay(Biogen (United States)), Stephen A. Woodcock(Biogen (United States)), Pornsri Lawton(Biogen (United States)), Christine Ambrose(Biogen (United States)), Manfred Baetscher(Oregon Health & Science University), Pascal Schneider(University of Lausanne), Jürg Tschopp(University of Lausanne), Jeffrey L. Browning(Biogen (United States))
The Journal of Experimental Medicine
December 6, 1999
Cited by 1,468Open Access
Full Text

Abstract

The cause of many autoimmune and inflammatory diseases is unresolved, although dysregulated production of tumor necrosis factor (TNF) family members appears to be important in many cases. BAFF, a new member of the TNF family, binds to B cells and costimulates their growth in vitro. Mice transgenic for BAFF have vastly increased numbers of mature B and effector T cells, and develop autoimmune-like manifestations such as the presence of high levels of rheumatoid factors, circulating immune complexes, anti-DNA autoantibodies, and immunoglobulin deposition in the kidneys. This phenotype is reminiscent of certain human autoimmune disorders and suggests that dysregulation of BAFF expression may be a critical element in the chain of events leading to autoimmunity.


Related Papers

No related papers found

Powered by citation graph analysis